Evidence has been presented suggesting the presence of vitamin D3 3β-glucosiduronate and 1,25-dihydroxyvitamin D3 glucosiduronate in rat bile. To evaluate the role of vitamin D glucosiduronates in calcium and phosphorus homeostasis, we synthesized vitamin D3 3β-glucosiduronate and tested its biological activity in calcium- and vitamin D-deficient rats. After the intravenous administration of vitamin D3 3β-glucosiduronate to rats maintained on a low calcium diet, there was an increase in duodenal calcium transport and an increase in serum calcium. Vitamin D3 3β-glucosiduronate, however, was less active than equimolar amounts of vitamin D3. At doses of less than 0.65-1 nmol per rat, the conjugate exhibited no activity. When vitamin D3 3β-glucosiduronate was administered to vitamin D-deficient rats, 25-hydroxyvitamin D was detected in the serum; the increase in serum 25-hydroxyvitamin D levels was less than that observed after the administration of an equimolar amount of vitamin D3. Vitamin D3 3β-glucosiduronate showed no detectable activity in the induction of calcium binding protein in chick embryonic duodena, a system in which no endogenous steroid β-glucuronidase activity is detectable. These data demonstrate that vitamin D3 3β-glucosiduronate is biologically active in vivo and that the observed activity is due to hydrolysis of the conjugate to vitamin D3. As vitamin D3 3β-glucosiduronate is excreted in the bile of rats, it is possible that this conjugate is reutilized in vivo after hydrolysis to free vitamin D3. These results suggest the existence of a mechanism for reutilization of the biliary products of vitamin D3.
Sreeramulu Nagubandi, Rajiv Kumar, James M. Londowski, R. A. Corradino, Pamela S. Tietz
The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.